 Heather Fairfield
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Myeloma | 13 | 2026 | 309 | 3.850 |
Why?
| | Bone Marrow | 9 | 2023 | 306 | 1.490 |
Why?
| | Adipocytes | 4 | 2021 | 223 | 1.280 |
Why?
| | Adipose Tissue | 4 | 2020 | 645 | 1.260 |
Why?
| | Bone Marrow Cells | 3 | 2020 | 321 | 1.160 |
Why?
| | Dietary Fiber | 1 | 2026 | 59 | 0.920 |
Why?
| | Fatty Acid-Binding Proteins | 2 | 2023 | 79 | 0.800 |
Why?
| | Exome | 4 | 2016 | 227 | 0.770 |
Why?
| | Tumor Microenvironment | 5 | 2026 | 734 | 0.660 |
Why?
| | Osteocytes | 2 | 2017 | 24 | 0.640 |
Why?
| | Models, Biological | 3 | 2018 | 1764 | 0.600 |
Why?
| | Obesity | 5 | 2026 | 3116 | 0.590 |
Why?
| | Cellular Senescence | 1 | 2020 | 226 | 0.540 |
Why?
| | Mutation | 8 | 2022 | 4075 | 0.540 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4560 | 0.520 |
Why?
| | Adipogenesis | 1 | 2017 | 56 | 0.500 |
Why?
| | Glycoproteins | 1 | 2017 | 354 | 0.440 |
Why?
| | Mice | 24 | 2026 | 18329 | 0.440 |
Why?
| | Mice, SCID | 3 | 2026 | 369 | 0.410 |
Why?
| | Mice, Inbred C57BL | 10 | 2026 | 5983 | 0.390 |
Why?
| | DNA Mutational Analysis | 3 | 2013 | 407 | 0.360 |
Why?
| | Animals | 28 | 2026 | 38030 | 0.350 |
Why?
| | Cancellous Bone | 2 | 2021 | 22 | 0.310 |
Why?
| | Genomics | 2 | 2015 | 825 | 0.310 |
Why?
| | Monoclonal Gammopathy of Undetermined Significance | 2 | 2023 | 11 | 0.310 |
Why?
| | Phenotype | 6 | 2020 | 3155 | 0.300 |
Why?
| | Osteogenesis | 3 | 2021 | 204 | 0.290 |
Why?
| | Disease Progression | 3 | 2026 | 2864 | 0.260 |
Why?
| | Neoplasm Proteins | 2 | 2023 | 441 | 0.250 |
Why?
| | Diet, High-Fat | 2 | 2026 | 266 | 0.240 |
Why?
| | Spermatogenesis | 2 | 2019 | 91 | 0.240 |
Why?
| | Stem Cell Niche | 2 | 2017 | 57 | 0.240 |
Why?
| | Coenzyme A Ligases | 1 | 2025 | 15 | 0.220 |
Why?
| | Extracellular Matrix Proteins | 1 | 2026 | 156 | 0.220 |
Why?
| | Genetic Diseases, Inborn | 2 | 2015 | 45 | 0.210 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2597 | 0.200 |
Why?
| | INDEL Mutation | 2 | 2014 | 22 | 0.200 |
Why?
| | Cell Line, Tumor | 6 | 2026 | 3542 | 0.190 |
Why?
| | Nails, Malformed | 1 | 2022 | 7 | 0.190 |
Why?
| | Nail Diseases | 1 | 2022 | 9 | 0.190 |
Why?
| | Adiposity | 2 | 2017 | 532 | 0.180 |
Why?
| | Enzyme Inhibitors | 1 | 2025 | 820 | 0.170 |
Why?
| | Cell Cycle | 2 | 2023 | 598 | 0.170 |
Why?
| | Whole-Body Irradiation | 1 | 2021 | 74 | 0.160 |
Why?
| | 3T3-L1 Cells | 2 | 2017 | 36 | 0.160 |
Why?
| | 3T3 Cells | 1 | 2020 | 156 | 0.160 |
Why?
| | Antibodies, Neutralizing | 2 | 2020 | 340 | 0.160 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2019 | 143 | 0.150 |
Why?
| | Coculture Techniques | 1 | 2020 | 247 | 0.150 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2020 | 43 | 0.150 |
Why?
| | Fatty Acids | 1 | 2023 | 457 | 0.150 |
Why?
| | Humans | 19 | 2026 | 145474 | 0.150 |
Why?
| | Receptors, IgG | 1 | 2020 | 77 | 0.150 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 1 | 2019 | 8 | 0.150 |
Why?
| | Spermatogonia | 1 | 2019 | 16 | 0.150 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2020 | 193 | 0.150 |
Why?
| | Frameshift Mutation | 2 | 2016 | 31 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2017 | 425 | 0.150 |
Why?
| | Cell Communication | 1 | 2020 | 328 | 0.140 |
Why?
| | T-Box Domain Proteins | 1 | 2019 | 106 | 0.140 |
Why?
| | Dexamethasone | 1 | 2020 | 365 | 0.140 |
Why?
| | Silk | 1 | 2018 | 4 | 0.140 |
Why?
| | Mitochondria | 1 | 2025 | 992 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2026 | 866 | 0.130 |
Why?
| | Bone and Bones | 2 | 2021 | 317 | 0.130 |
Why?
| | Cortical Bone | 1 | 2017 | 15 | 0.130 |
Why?
| | Genetic Linkage | 2 | 2015 | 272 | 0.130 |
Why?
| | Culture Media, Conditioned | 1 | 2017 | 112 | 0.130 |
Why?
| | Biopsy | 1 | 2020 | 1082 | 0.130 |
Why?
| | Female | 11 | 2026 | 78844 | 0.130 |
Why?
| | Alleles | 4 | 2016 | 894 | 0.130 |
Why?
| | Mutation, Missense | 2 | 2016 | 335 | 0.120 |
Why?
| | Paracrine Communication | 1 | 2017 | 67 | 0.120 |
Why?
| | Gray Platelet Syndrome | 1 | 2016 | 4 | 0.120 |
Why?
| | Killer Cells, Natural | 1 | 2020 | 480 | 0.120 |
Why?
| | Apoptosis | 2 | 2025 | 2440 | 0.120 |
Why?
| | Gonadal Steroid Hormones | 1 | 2017 | 143 | 0.120 |
Why?
| | Base Pairing | 1 | 2016 | 65 | 0.120 |
Why?
| | Male | 10 | 2026 | 72842 | 0.120 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 20 | 0.120 |
Why?
| | Leptin | 1 | 2017 | 248 | 0.120 |
Why?
| | Gene Expression | 1 | 2020 | 1476 | 0.110 |
Why?
| | Hyperpigmentation | 1 | 2016 | 27 | 0.110 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 376 | 0.110 |
Why?
| | Maxillofacial Development | 1 | 2015 | 20 | 0.110 |
Why?
| | Bone Remodeling | 1 | 2016 | 71 | 0.110 |
Why?
| | Antibodies, Monoclonal | 2 | 2020 | 1505 | 0.110 |
Why?
| | Tissue Scaffolds | 1 | 2018 | 221 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2026 | 3124 | 0.110 |
Why?
| | Proteomics | 2 | 2023 | 1188 | 0.110 |
Why?
| | Keratoderma, Palmoplantar | 1 | 2015 | 6 | 0.110 |
Why?
| | Hair Diseases | 1 | 2015 | 10 | 0.110 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 211 | 0.110 |
Why?
| | Desmoplakins | 1 | 2015 | 24 | 0.110 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 881 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 530 | 0.110 |
Why?
| | Osteoblasts | 3 | 2021 | 145 | 0.110 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 78 | 0.110 |
Why?
| | Hydronephrosis | 1 | 2015 | 36 | 0.110 |
Why?
| | Pyrophosphatases | 1 | 2014 | 26 | 0.110 |
Why?
| | Transplantation, Autologous | 1 | 2016 | 300 | 0.110 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2014 | 52 | 0.110 |
Why?
| | Stem Cell Transplantation | 1 | 2016 | 189 | 0.110 |
Why?
| | Hair | 1 | 2015 | 84 | 0.110 |
Why?
| | Organogenesis | 1 | 2015 | 63 | 0.110 |
Why?
| | Exons | 2 | 2016 | 363 | 0.110 |
Why?
| | Tumor Burden | 1 | 2016 | 325 | 0.110 |
Why?
| | Urogenital Abnormalities | 1 | 2015 | 71 | 0.100 |
Why?
| | Blood Proteins | 1 | 2016 | 239 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2019 | 910 | 0.100 |
Why?
| | Mice, Inbred Strains | 2 | 2011 | 396 | 0.100 |
Why?
| | Metformin | 1 | 2017 | 329 | 0.100 |
Why?
| | Genetic Association Studies | 1 | 2015 | 369 | 0.100 |
Why?
| | Tissue Engineering | 1 | 2018 | 439 | 0.100 |
Why?
| | NADPH Oxidases | 2 | 2010 | 122 | 0.100 |
Why?
| | Quality of Life | 1 | 2026 | 3204 | 0.100 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2013 | 40 | 0.100 |
Why?
| | Vascular Calcification | 1 | 2014 | 110 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 487 | 0.100 |
Why?
| | Infertility, Male | 1 | 2013 | 80 | 0.100 |
Why?
| | Bone Diseases | 1 | 2013 | 61 | 0.090 |
Why?
| | Lipids | 1 | 2018 | 707 | 0.090 |
Why?
| | Cytokines | 1 | 2020 | 2067 | 0.090 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1454 | 0.090 |
Why?
| | Infertility, Female | 1 | 2013 | 122 | 0.090 |
Why?
| | Chromosomes, Mammalian | 1 | 2011 | 28 | 0.090 |
Why?
| | Fractures, Bone | 1 | 2017 | 428 | 0.090 |
Why?
| | Collagen Type II | 1 | 2011 | 53 | 0.090 |
Why?
| | Indicators and Reagents | 1 | 2011 | 106 | 0.090 |
Why?
| | Precision Medicine | 1 | 2016 | 459 | 0.080 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2011 | 70 | 0.080 |
Why?
| | Cardiomyopathies | 1 | 2015 | 335 | 0.080 |
Why?
| | Ear, Inner | 1 | 2010 | 51 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 2011 | 506 | 0.080 |
Why?
| | Gene Frequency | 1 | 2011 | 487 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 972 | 0.080 |
Why?
| | Phagocytes | 1 | 2010 | 80 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 6013 | 0.080 |
Why?
| | Cell Survival | 2 | 2025 | 1100 | 0.080 |
Why?
| | Aging | 1 | 2020 | 1969 | 0.080 |
Why?
| | Genotype | 2 | 2011 | 1852 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2010 | 172 | 0.070 |
Why?
| | Transcription Factors | 2 | 2015 | 1734 | 0.070 |
Why?
| | Terminal Repeat Sequences | 1 | 2008 | 17 | 0.070 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 2008 | 42 | 0.070 |
Why?
| | Genome-Wide Association Study | 1 | 2015 | 1407 | 0.070 |
Why?
| | Prolactin | 1 | 2008 | 87 | 0.070 |
Why?
| | Genetic Markers | 2 | 2019 | 335 | 0.060 |
Why?
| | Kidney | 1 | 2015 | 1497 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3413 | 0.060 |
Why?
| | Progesterone | 1 | 2008 | 215 | 0.060 |
Why?
| | Base Sequence | 3 | 2016 | 2170 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2017 | 108 | 0.060 |
Why?
| | Antibodies | 2 | 2019 | 397 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2016 | 2883 | 0.060 |
Why?
| | Triazenes | 1 | 2025 | 6 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2025 | 2507 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2214 | 0.050 |
Why?
| | Proteins | 1 | 2010 | 1023 | 0.050 |
Why?
| | Cyclobutanes | 1 | 2023 | 7 | 0.050 |
Why?
| | Dicarboxylic Acids | 1 | 2023 | 12 | 0.050 |
Why?
| | Growth and Development | 1 | 2022 | 9 | 0.050 |
Why?
| | Nails | 1 | 2022 | 14 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1716 | 0.050 |
Why?
| | Horses | 1 | 2022 | 226 | 0.040 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 174 | 0.040 |
Why?
| | Teriparatide | 1 | 2019 | 10 | 0.040 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2019 | 25 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 52 | 0.040 |
Why?
| | Testis | 1 | 2019 | 162 | 0.030 |
Why?
| | Parathyroid Hormone | 1 | 2019 | 114 | 0.030 |
Why?
| | Adipose Tissue, White | 1 | 2017 | 43 | 0.030 |
Why?
| | Dihydrotestosterone | 1 | 2017 | 40 | 0.030 |
Why?
| | Androgen Receptor Antagonists | 1 | 2017 | 35 | 0.030 |
Why?
| | Cell Count | 1 | 2017 | 319 | 0.030 |
Why?
| | Diphosphonates | 1 | 2017 | 68 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 461 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2017 | 182 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2017 | 277 | 0.030 |
Why?
| | Emperipolesis | 1 | 2016 | 1 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 2016 | 13 | 0.030 |
Why?
| | Imidazoles | 1 | 2017 | 247 | 0.030 |
Why?
| | Osteopetrosis | 1 | 2015 | 2 | 0.030 |
Why?
| | Tooth Eruption | 1 | 2015 | 10 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 450 | 0.030 |
Why?
| | Cephalometry | 1 | 2015 | 30 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 886 | 0.030 |
Why?
| | Biopsy, Needle | 1 | 2016 | 185 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 507 | 0.030 |
Why?
| | Neutropenia | 1 | 2016 | 154 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 365 | 0.030 |
Why?
| | Stem Cells | 1 | 2019 | 628 | 0.030 |
Why?
| | Fertility | 1 | 2016 | 173 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 156 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2017 | 572 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 730 | 0.030 |
Why?
| | Skull | 1 | 2015 | 162 | 0.030 |
Why?
| | Thrombocytopenia | 1 | 2016 | 204 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 529 | 0.030 |
Why?
| | Face | 1 | 2015 | 174 | 0.030 |
Why?
| | Chromosome Pairing | 1 | 2013 | 11 | 0.030 |
Why?
| | Spleen | 1 | 2016 | 508 | 0.030 |
Why?
| | Estradiol | 1 | 2017 | 515 | 0.020 |
Why?
| | Body Composition | 1 | 2017 | 693 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2524 | 0.020 |
Why?
| | Cardiovascular System | 1 | 2014 | 138 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2013 | 302 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2015 | 317 | 0.020 |
Why?
| | Point Mutation | 1 | 2013 | 240 | 0.020 |
Why?
| | Genetic Loci | 1 | 2013 | 264 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2016 | 2129 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 777 | 0.020 |
Why?
| | Metabolomics | 1 | 2017 | 732 | 0.020 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2015 | 356 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2015 | 583 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 2046 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1997 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5584 | 0.020 |
Why?
| | Neutrophils | 1 | 2016 | 1124 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4148 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2010 | 153 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 767 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2010 | 335 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1190 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 977 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2158 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2008 | 88 | 0.020 |
Why?
| | Mammary Glands, Human | 1 | 2008 | 68 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 611 | 0.020 |
Why?
| | Drug Synergism | 1 | 2008 | 354 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 191 | 0.020 |
Why?
| | Transfection | 1 | 2008 | 926 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2010 | 2188 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2769 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 2238 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2008 | 2382 | 0.010 |
Why?
|
|
Fairfield's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|